Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-29T10:42:22.025Z Has data issue: false hasContentIssue false
  • English
  • Français

Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction?

Published online by Cambridge University Press:  18 May 2011

Corrado Barbui  and
Michele Tansella
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 16 , Issue 3 , September 2007 , pp. 189 - 191
Copyright
Copyright © Cambridge University Press 2007

References

REFERENCES

Adams, C. & Jayaram, M. (2007). Do findings from new trials for schizophrenia fit with existing evidence: not duped just beguiled? Epidemiologia e Psichiatria Sociale 16, 199–202.Google Scholar
Barbui, C. & Cipriani, A. (2007). Evidence-based psychopharmacology: an agenda for the future. Evidence Based Mental Health 10, 4–6.Google Scholar
Barbui, C. & Garattini, S. (2007). Regulatory policies on medicines for psychiatric disorders: is Europe on target? British Journal of Psychiatry 190,91–93.Google Scholar
Healy, D. (2007). The engineers of human souls & academia. Epidemiologia e Psichiatria Sociale 16, 205–211.Google Scholar
Moncrieff, J. (2007). Co-opting psychiatry: the alliance between academic psychiatry and the pharmaceutical industry. Epidemiologia e Psichiatria Sociale 16, 192–196.Google Scholar
Pilling, S. & Price, K. (2006). Developing and implementing clinical guidelines: lessons from the NICE Schizophrenia Guideline. Epidemiologia e Psichiatria Sociale 15, 109–116.Google Scholar
Tognoni, G. & Franzosi, M.G. (2005). [Experimenting in Italy: from GIS-SI to the Ministerial Decree]. Recenti Progressi in Medicina 96, 92–94.Google Scholar
Tohen, M. (2007). Collaborations between academic psychiatry and the pharmaceutical industry: A perspective from industry. Epidemiologia e Psichiatria Sociale 16, 197–198.Google Scholar